Empowering the Next Generation of Biotech
At Group 3CS, we connect science with strategy. By guiding biotech organizations through growth, transformation, and innovation, we help them build a smarter, more sustainable future.
We work to improve the quality of life of patients with spinal cord injuries, stroke, and other disorders affecting the central nervous system. Through research, innovation, and collaboration, we aim to advance neurological recovery and care.
Biotech Business Development
We support biotechnology companies in identifying growth opportunities, optimizing operations, and expanding their market impact. Our strategic guidance helps turn scientific potential into sustainable business success.
Biotech Innovation
We help biotech organizations adopt cutting-edge technologies and advance breakthrough solutions. By fostering creativity and operational excellence, we accelerate the transformation of research into real-world impact.
Antonio Oliveiro
General Division Manager
Neurologist and neuroscientist with 20+ years of experience in central nervous system research, neuromodulation, and motor cortex function. Author of 200+ peer-reviewed articles with 21,000+ citations (H-index 64). Former leader of FENNSI at the National Hospital for Paraplegics, and currently Chief Medical Officer at Neurofix Pharma, driving clinical and medical research.